UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Head & neck, 2021-11, Vol.43 (11), p.3408-3416

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Cancer, 2020-01, Vol.126 (2), p.354-362

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma

Head & neck, 2018-07, Vol.40 (7), p.1555-1564

2018

Link zum Volltext

Verfügbarkeit prüfen

Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors

The Laryngoscope, 2021-07, Vol.131 (7), p.E2413-E2419

2021

Link zum Volltext

Verfügbarkeit prüfen

Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient

Head & neck, 2020-10, Vol.42 (10), p.E16-E22

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6141-6146

2020

Link zum Volltext

Verfügbarkeit prüfen

Papillomavirus E6 and E7 proteins and their cellular targets

Frontiers in bioscience, 2008-01, Vol.13, p.1003

2008

Link zum Volltext

Verfügbarkeit prüfen

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Head & neck, 2023-01, Vol.45 (1), p.212-224

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Frontiers in immunology, 2023-03, Vol.14, p.1184007-1184007

2023

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis

Cancers, 2021-07, Vol.13 (15), p.3677

2021

Link zum Volltext

Verfügbarkeit prüfen

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3217

2024

Link zum Volltext

Verfügbarkeit prüfen

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005632

2022

Link zum Volltext

Verfügbarkeit prüfen

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity

Cancers, 2022-07, Vol.14 (15), p.3564

2022

Link zum Volltext

Verfügbarkeit prüfen

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8 + T Cells in Head and Neck Cancer

Frontiers in pharmacology, 2020-02, Vol.11, p.143-143

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes

Cancers, 2021-12, Vol.13 (24), p.6309

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitors Regulate K+ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients

Frontiers in pharmacology, 2021-08, Vol.12, p.742862-742862

2021

Link zum Volltext

Verfügbarkeit prüfen

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma

Cancers, 2024-02, Vol.16 (5), p.1008

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Cancers, 2022-05, Vol.14 (10), p.2355

2022

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus induced transformation in cervical and head and neck cancers

Cancers, 2014-09, Vol.6 (3), p.1793-1820

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Cancer discovery, 2020-05, Vol.10 (5), p.688-701

2020

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Molecular and Cellular Biology, 2006-10, Vol.26 (20), p.7506-7519

2006

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1792-1799

2009

Link zum Volltext

Verfügbarkeit prüfen

Managing Recurrent Metastatic Head and Neck Cancer

Hematology/oncology clinics of North America, 2021-10, Vol.35 (5), p.1009

2021

Link zum Volltext

Verfügbarkeit prüfen

Future directions and treatment strategies for head and neck squamous cell carcinomas

Translational research : the journal of laboratory and clinical medicine, 2012-09, Vol.160 (3), p.167-177

2012

Link zum Volltext

Verfügbarkeit prüfen

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Journal of Virology, 2005-11, Vol.79 (22), p.14309-14317

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(92)

Sprache

Englisch
(92)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma

Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors

Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Papillomavirus E6 and E7 proteins and their cellular targets

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8 + T Cells in Head and Neck Cancer

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes

Immune Checkpoint Inhibitors Regulate K+ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Human papillomavirus induced transformation in cervical and head and neck cancers

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Managing Recurrent Metastatic Head and Neck Cancer

Future directions and treatment strategies for head and neck squamous cell carcinomas

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Suchergebnisse filtern